# Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer

> **NCT00046540** · PHASE1 · COMPLETED · sponsor: **INSYS Therapeutics Inc** · enrollment: 40 (—)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** Liposome-encapsulated SN38

## Key facts

- **NCT ID:** NCT00046540
- **Lead sponsor:** INSYS Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2007-08
- **Final completion:** 2010-11
- **Target enrollment:** 40 (—)
- **Last updated:** 2011-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046540, "Liposome Encapsulated SN38 (LE-SN38) in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00046540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*